Published September 30, 2023 | Version https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue9,Article143.pdf
Journal article Open

Comparative Study of Pneumothorax Cases in COVID-19 and NonCOVID-19 Patients

  • 1. Assistant Professor, Department of Pulmonary Medicine, SVP Hospital, Smt NHL Municipal Medical College, Ahmedabad, Gujarat, India
  • 2. Associate Professor, Department of Emergency Medicine, Sheth L.G. General Hospital, Narendra Modi Medical College, Ahmedabad, Gujarat, India
  • 3. Senior Resident, Department of Pulmonary Medicine, SVP Hospital, Smt NHL Municipal Medical College, Ahmedabad, Gujarat, India

Description

Introduction: The pneumothorax is a potential life threatening emergency if not treated in timely manner. Aim of this study to compare characteristics and outcome between Non COVID and COVID patients having pneumothorax. Materials and Methods: All patients who had pneumothorax were included in study and divided in two groups: Non COVID and COVID positive patients. Clinical and demographic detail of each patient was obtained from the hospital information system and entered in case records forms. Results: Total 104 patients having pneumothorax were included. Out of them, 63 (60.57%) were male. Trauma was most common cause in Non COVID patients. The mortality rate in COVID patients with pneumothorax (89.36%) was significantly higher than Non COVID patients (29.82%, p < 0.001). Conclusion: Pneumothorax in COVID-19 patients is more common in older age groups, often accompanied by comorbidities, and has a higher mortality rate compared to non-COVID-19 patients with pneumothorax.

 

 

Abstract (English)

Introduction: The pneumothorax is a potential life threatening emergency if not treated in timely manner. Aim of this study to compare characteristics and outcome between Non COVID and COVID patients having pneumothorax. Materials and Methods: All patients who had pneumothorax were included in study and divided in two groups: Non COVID and COVID positive patients. Clinical and demographic detail of each patient was obtained from the hospital information system and entered in case records forms. Results: Total 104 patients having pneumothorax were included. Out of them, 63 (60.57%) were male. Trauma was most common cause in Non COVID patients. The mortality rate in COVID patients with pneumothorax (89.36%) was significantly higher than Non COVID patients (29.82%, p < 0.001). Conclusion: Pneumothorax in COVID-19 patients is more common in older age groups, often accompanied by comorbidities, and has a higher mortality rate compared to non-COVID-19 patients with pneumothorax.

 

 

Files

IJPCR,Vol15,Issue9,Article143.pdf

Files (427.2 kB)

Name Size Download all
md5:8528ca806018e43c8fbbc3347a3fe7c0
427.2 kB Preview Download

Additional details

Dates

Accepted
2023-08-30

References

  • 1. Ministry of Health and Family Welfare [Internet]. Available from: https://www.mohfw.gov.in/. [Accessed 10th Sept 2023]. 2. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021; 19(3) 141–54. 3. 3. Martinelli AW, Ingle T, Newman J, Nadeem I, Jackson K, Lane ND, et al. COVID19 and pneumothorax: a multicentre retrospective case series. Eur Respir J 2020; 56(5) 2002697. 4. Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507–13. 5. Shan, S.; Guangming, L.; Wei, L.; Xuedong, Y. Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19: Case report and literature review. Rev Inst Med Trop São Paulo 2020, 62, e76. 6. Jamous, F.; Meyer, N.; Buus, D.; Ateeli, H.; Taggart, K.; Devasahayam, J.; Hanson, T.; Alzoubaidi, M.; Nazir, J. Critical illness due to COVID-19: A description of the surge in a single center in Sioux Falls. S D Med 2020, 73, 312–7. 7. Yao, W.; Wang, T.; Jiang, B.; Gao, F.; Wang, L.; Zheng, H.; Xiao, W.; Yao, S.; Mei, W.; Nishikawa, K. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: Lessons learnt and international expert recommendations. Br J Anaesth 2020, 125, e28–e37. 8. Yang, F.; Shi, S.; Zhu, J.; Shi, J.; Dai, K.; Chen, X. Analysis of 92 deceased patients with COVID-19. J Med Virol 2020, 92, 2511–5. 9. Wang XH, Duan J, Han X, Liu X, Zhou J, Wang X, et al. High incidence and mortality ofpneumothorax in critically ill patients with COVID-19. Hear Lung 2021; 50(1) 37–43. 10. Elhakim TS, Abdul HS, Pelaez Romero C, Rodriguez-Fuentes Y. Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19 pneumonia: a rare case and literature review. BMJ Case Rep 2020; 13(12) e239489. 11. Zantah M, Dominguez Castillo E, Townsend R, Dikengil F, Criner GJ. Pneumothorax in COVID-19 disease: Incidence and clinical characteristics. Respir Res 2020; 21(1) 236. 12. Chong WH, Saha BK, Hu K, Chopra A. The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: A systematic review. Hear Lung 2021; 50(5) 599–608. 13. Miró Ò, Llorens P, Jiménez S et al. Frequency, risk factors, clinical characteristics, and outcomes of spontaneous pneumothorax in patients with coronavirus disease 2019: a casecontrol, emergency medicine-based multicenter study. Chest 2020;159:1241–55. 14. Udwadia ZF, Toraskar KK, Pinto L, Mullerpatan J, Wagh HD, Mascarenhas JM, Gandhi BM, Tripathi A, Sunavala A, Agrawal U, Nanda V. Increased frequency of pneumothorax and pneumomediastinum in COVID-19 patients admitted in the ICU: A multicentre study from M. Clin Med 2021 Nov;21(6)e615. 15. Singh A. Pneumothorax in Critically Ill COVID-19 Patients in the Indian Subcontinent. Romanian Journal of Anaesthesia and Intensive Care. 2022 Jul 1;29(1)8-15. 16. Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, et al. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Hear J 2021 Jun 14; 42(23) 2270- 9. 17. Chu CM, Leung YY, Hui JYH, Hung IFN, Chan VL, Leung WS, et al. Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome. Eur Respir J 2004; 23 802–4.